DiaMedica Therapeutics (DMAC) Insider Trading & Ownership $3.64 +0.08 (+2.10%) As of 10:10 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock DiaMedica Therapeutics (NASDAQ:DMAC) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage7.30%Number OfInsiders Buying(Last 3 Years)5Amount OfInsider Buying(Last 3 Years)$9.65MNumber OfInsiders Selling(Last 3 Years)0 Get DMAC Insider Trade Alerts Want to know when executives and insiders are buying or selling DiaMedica Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address DMAC Insider Buying and Selling by Quarter DiaMedica Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails6/28/2024Koch Thomas VonMajor ShareholderBuy1,200,000$2.50$3,000,000.00 6/23/2023David J WambekeInsiderBuy38,364$3.91$150,003.24 6/23/2023Dietrich John PaulsCEOBuy12,787$3.91$49,997.17 6/23/2023Koch Thomas VonMajor ShareholderBuy1,470,588$3.40$4,999,999.20 6/23/2023Randall Michael GiuffreDirectorBuy65,000$3.91$254,150.00 6/23/2023Scott KellenCFOBuy10,000$3.91$39,100.00 4/10/2023David J WambekeInsiderBuy468,750$1.60$750,000.00 12/8/2022Randall Michael GiuffreDirectorBuy20,000$1.40$28,000.00 12/6/2022Randall Michael GiuffreDirectorBuy2,300$1.35$3,105.00 12/1/2022Randall Michael GiuffreDirectorBuy46,133$1.20$55,359.60 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 11/29/2022Randall Michael GiuffreDirectorBuy18,125$1.19$21,568.75 11/16/2022Dietrich John PaulsCEOBuy20,000$1.21$24,200.00 7/8/2022Koch Thomas VonMajor ShareholderBuy207,974$1.33$276,605.42 (Data available from 1/1/2013 forward) DMAC Insider Trading Activity - Frequently Asked Questions Who is on DiaMedica Therapeutics' Insider Roster? The list of insiders at DiaMedica Therapeutics includes David J Wambeke, Dietrich John Pauls, Koch Thomas Von, Randall Michael Giuffre, and Scott Kellen. Learn more on insiders at DMAC. What percentage of DiaMedica Therapeutics stock is owned by insiders? 7.30% of DiaMedica Therapeutics stock is owned by insiders. Learn more on DMAC's insider holdings. Which DiaMedica Therapeutics insiders have been buying company stock? The following insider purchased DMAC shares in the last 24 months: Koch Thomas Von ($3,000,000.00). How much insider buying is happening at DiaMedica Therapeutics? Insiders have purchased a total of 1,200,000 DMAC shares in the last 24 months for a total of $3,000,000.00 bought. More Insider Trading Tools from MarketBeat Related Companies Nuvation Bio Insider Trades Day One Biopharmaceuticals Insider Trades Stoke Therapeutics Insider Trades Sana Biotechnology Insider Trades Maravai LifeSciences Insider Trades Urogen Pharma Insider Trades ChromaDex Insider Trades Cidara Therapeutics Insider Trades Evolus Insider Trades Upstream Bio Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles The Top Insider Sells From Q2: Buy, Sell, or Hold?3 Hot Trades for Insiders, But Are They Good Buys for Investors?Insiders Chase Income and Stability in American Tower—Here’s Why3 Tech Stocks With High and Rising Institutional Interest3 Summer Stocks With Insider Buying and Analyst Support This page (NASDAQ:DMAC) was last updated on 7/2/2025 by MarketBeat.com Staff From Our PartnersWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | Sponsored379 passengers walked away from thisWhy Elon Musk Just Invested $51 Million Into Brand New “Miracle Metal” Developed by MIT ScientistsTrue Market Insiders | SponsoredCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredThe #1 AI Energy StockNearly $600 billion is projected to be spent on AI data centers this year. That's because the ones being bu...Weiss Ratings | SponsoredTrump set to Boost Social Security Checks by 400%?If you collect—or plan to collect—Social Security, you need to see this. A new initiative tied to President...InvestorPlace | SponsoredI was wrong about TrumpI made a mistake. A mistake I feel very foolish about. After speaking with Donald Trump and some of his ...Porter & Company | Sponsored“E.I.”- The biggest prediction of my career?One expert predicts that E.I. could see over 200,000% growth... But you need to move fast...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding DiaMedica Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share DiaMedica Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
